# Immune Regulation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/immune-regulation

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.immuneregulation.com
- Total disclosed funding: $58M
- Latest round: Series B (Sep 21, 2020)
- Investors on record: 4

## About

Immune Regulation Limited specializes in digital real estate, focusing on the sale of its domain name, facilitating online presence in health and regulatory sectors for businesses and individuals.Founded in 2011, Immune Regulation Limited operates from Cambridge, UK, primarily engaging in the digital domain market. The company has completed a total of 6 deals, with its latest funding round being a Series B, raising GBP 40.60 mn on September 21, 2020, led by Morningside Venture Partners and supported by investors 24Haymarket and Metellus. The CEO, Woody Bryan, has a history of leadership in business development within the technology sector.Immune Regulation Limited offers its domain name, available for direct purchase or structured payment plans, catering to startups, healthcare organizations, and research institutions seeking to establish their online identity in the health and regulatory fields. This service is marketed globally, targeting clients interested in health, biotechnology, and regulatory affairs.In the most recent year, Immune Regulation Limited reported zero revenue, with an EBITDA of GBP -19,215,583.80 for 2024.The company plans to leverage its recent Series B funding of GBP 40.60 mn to enhance its domain sales strategy and expand into new geographic markets. Specific initiatives include the development of new digital products aimed at improving customer engagement and satisfaction, with a focus on increasing market penetration in Europe and North America by 2025. The funding will also support marketing efforts to reach a broader audience within the health sector.

## Funding rounds

- Series B, Sep 21, 2020, $53M — 24Haymarket, Metellus, Morningside
- Series A, Sep 28, 2017, $5.5M — 24Haymarket, NCL Technology Ventures

## Investors

- 24Haymarket (https://capitalatlas.ai/funds/24haymarket) — Series A, Series B
- NCL Technology Ventures (https://capitalatlas.ai/funds/ncl-technology-ventures) — Series A
- Metellus (https://capitalatlas.ai/funds/metellus) — Series B
- Morningside (https://capitalatlas.ai/funds/morningside) — Series B